Titre : | European Addiction Research, Vol.23, n°5 - November 2017 |
Type de document : | Bulletin : Périodique |
Paru le : | 01/11/2017 |
Année de publication : | 2017 |
Format : | 219-268 |
Langues: | Anglais |
Note de contenu : |
CONTENTS:
- Reduced drinking in alcohol dependence treatment, what is the evidence? Mann K., Aubin H.J., Witkiewitz K., p. 219-230. - Predictors of persistence of risky drinking in adults: An 11-year follow-up study. Harkonen J., Aalto M., Suvisaari J., Lintonen T., Maki-Opas T., Pena S., et al., p. 231-237. - Development of OSTQOL: A Measure of quality of life for patients in opioid substitution treatment. Strada L., Franke G.H., Schulte B., Reimer J., Verthein U., p. 238-248. - Epigenetic regulation of the promotor region of vascular endothelial growth factor-A and nerve growth factor in opioid-maintained patients. Groh A., Jahn K., Burkert A., Neyazi A., Schares L., Janke E., et al., p. 249-259. - The Depression, Anxiety and Stress Scale (DASS-21) as a screener for depression in substance use disorder inpatients: A pilot study. Beaufort I.N., De Weert-Van Oene G.H., Buwalda V.A.J., de Leeuw J.R.J., Goudriaan A.E., p. 260-268. |
Cote : | Abonnement |
Lien : | https://www.karger.com/Journal/Issue/276823 |
Dépouillements
Ajouter le résultat dans votre panierArticle : Périodique
K. MANN ;
H. J. AUBIN ;
K. WITKIEWITZ
|
Abstinence from alcohol has been the prevailing treatment goal for individuals with alcohol dependence (AD) within the context of specialty alcohol treatment. Yet, alcohol use has been conceptualized as existing on a continuum. Importantly, most[...]
Exemplaires
Disponibilité |
---|
aucun exemplaire |
